|
DESIGN OF UNIVERSAL H5 INFLUENZA VIRUS VACCINE CANDIDATES VIA ANTIGEN REORIENTATION
DESIGN OF UNIVERSAL H5 INFLUENZA VIRUS VACCINE CANDIDATES VIA ANTIGEN REORIENTATION
Researchers at Stanford University have developed novel universal vaccine candidates for H5 influenza viruses.
Influenza remains a serious threat to public health. H5 avian influenza strains are among the most concerning despite lack of documented human to human...
Published: 9/24/2024
|
Inventor(s): Duo Xu, Peter Kim
Keywords(s): Immunofocusing, Vaccine
Category(s): Technology Classifications > Biology
|
|
DESIGN OF A UNIVERSAL INFLUENZA VACCINE CANDIDATES VIA ANTIGEN REORIENTATION
DESIGN OF A UNIVERSAL INFLUENZA VACCINE CANDIDATES VIA ANTIGEN REORIENTATION
Researchers at Stanford have developed a novel universal influenza vaccine candidate.
Vaccines are a major feat of biomedical innovation. Successful vaccines produce broad humoral immunity to a pathogen to prevent subsequent infection. In this vein, adjuvants are compounds...
Published: 12/5/2023
|
Inventor(s): Duo Xu, Peter Kim
Keywords(s): Adjuvant, Alum, Infectious Disease, Vaccine
Category(s): Technology Classifications > Biology
|
|
IMMUNOGENIC EBOLAVIRUS FUSION PROTEINS AND RELATED METHODS
IMMUNOGENIC EBOLAVIRUS FUSION PROTEINS AND RELATED METHODS
Researchers at Stanford have developed a novel vaccine strategy for ebolavirus using fusion proteins composed of the virus’ glycoprotein.
Hemorrhagic fevers have become a major public health issue in Africa, the most notable of which being Ebola. Ebola has a notably high mortality...
Published: 10/6/2023
|
Inventor(s): Peter Kim, Duo Xu, Abigail Powell
Keywords(s): Ebola Virus, Infectious Disease, Vaccine
Category(s): Technology Classifications > Biology
|
